Background. As in most industrialized countries, living kidney donation has increased considerably in the UK and now amounts to 38% of the total UK kidney transplant activity. Living kidney donation guidelines have been formulated by the relevant national societies. We were interested to study whether or not renal units across the UK adhere to those guidelines and to delineate areas of inconsistency and controversy. Methods. Twenty-four adult kidney transplant centres and 50 adult non-transplant renal units across the UK were contacted by a postal questionnaire from January to April 2011. Results. Twenty-one of 24 (88%) transplanting units and 23 of 50 (46%) non-transplanting units responded. Eighty-one per cent of the responding transplanting units and only 30% of the non-transplanting units have a dedicated live donor clinic. Eighty-six per cent of all units are without a set upper age limit for donors, whereas 7% of units excluded all potential donors older than 70 years. Twenty per cent of units accept donors with body mass indices (BMIs) up to 35, whereas 9% of units did not have an upper limit for BMI. Thirty-two per cent of centres exclude hypertensive donors on more than one antihypertensive drug, whereas 64% of units exclude donors only if they are on more than two anti-hypertensive drugs. of units rely on a spot urine sample to assess proteinuria, while 30% of units still perform 24 h urine collection. Sixty one per cent of units perform computed tomography (CT)
A B S T R AC T
Background. As in most industrialized countries, living kidney donation has increased considerably in the UK and now amounts to 38% of the total UK kidney transplant activity. Living kidney donation guidelines have been formulated by the relevant national societies. We were interested to study whether or not renal units across the UK adhere to those guidelines and to delineate areas of inconsistency and controversy. Methods. Twenty-four adult kidney transplant centres and 50 adult non-transplant renal units across the UK were contacted by a postal questionnaire from January to April 2011. Results. Twenty-one of 24 (88%) transplanting units and 23 of 50 (46%) non-transplanting units responded. Eighty-one per cent of the responding transplanting units and only 30% of the non-transplanting units have a dedicated live donor clinic. Eighty-six per cent of all units are without a set upper age limit for donors, whereas 7% of units excluded all potential donors older than 70 years. Twenty per cent of units accept donors with body mass indices (BMIs) up to 35, whereas 9% of units did not have an upper limit for BMI. Thirty-two per cent of centres exclude hypertensive donors on more than one antihypertensive drug, whereas 64% of units exclude donors only if they are on more than two anti-hypertensive drugs. of units rely on a spot urine sample to assess proteinuria, while 30% of units still perform 24 h urine collection. Sixty one per cent of units perform computed tomography (CT) angiography to assess the renal vessels prior to donation, while 32% use magnetic resonance (MR) angiography. Seventy-five per cent of centres assess split kidney function by radionuclide testing in all cases, whereas 25% perform this test only if there is a discrepancy in kidney size. The practice of suspension of recipients with potential living donor from the deceased waiting list is also remarkably inconsistent, whereby some centres suspend once a decision for living donation has been made in principle, whereas others suspend the recipient only once a date for surgery has been agreed. Conclusions. We demonstrate significant variability in accepting living kidney donors, particularly regarding age, BMI, and hypertension. Infrastructure setting for living donation and the live donor assessment are also remarkably inconsistent across the UK. It remains unclear as to why nephrologists decide not to adhere to established guidelines and further research should aim to find the lacking evidence in areas causing inconsistency in living donor assessment.
I N T RO D U C T I O N
Initially devised to address the lack of deceased donors in relation to the growing need for organs, living kidney donation (LKD) has now become the preferred treatment option for suitable patients with end-stage renal failure. LKD allows pre-emptive transplantation and also provides better long-term patient and graft survival when compared with deceased-donor transplantation [1] . It is therefore not surprising that initiatives within the renal community [2] and national renal policies [3] promote LKD. As a consequence, LKD numbers are still increasing in many developed countries. The UK, for example, has seen a 93% increase in the annual rate of LKD between 2000 and 2006 [3] .
Such a drive for an increase in LKD must be balanced against the safety of the donor [4] . Large studies report the peri-operative donor mortality to be in the range of 0.03% [5, 6] . Other major and minor peri-operative complications have been reported to occur in 0.2 and 8% of donors, respectively [7] . Other series have reported no donor mortality but slightly higher morbidity [8] . Long-term, LKD is generally considered to be safe for the vast majority of healthy donors with survival rates similar to those of matched controls [9] .
It is tempting to think, although not proven, that a thorough evaluation of the prospective donor will result in low peri-operative morbidity and mortality. Serious complications or death in a previously healthy donor are not only an individual catastrophe, but also jeopardize the reputation and success of a transplant programme and may, in the extreme, also affect national attitudes towards live donation. Bearing this in mind it is clear that there is a need for standardized living donor evaluation to establish the donor safety. The UK is one of the few countries to have established donor evaluation guidelines [10] . We were interested in studying whether or not UK nephrologists and surgeons adhere to these guidelines.
S U B J E C T S A N D M E T H O D S
We aimed here to study the different practices of living kidney donor assessment in the UK. We devised a structured questionnaire with 21 questions to gather information relating to the living kidney donor evaluation, selection and follow-up (Figure 1) . We obtained the names and addresses of the 74 UK hub adult renal units from the UK Renal Association website (Figure 2) . We sent the questionnaire between January and April 2011, including both transplant units (centres performing the transplant surgery) and nontransplant Units (centres performing all or part of the live kidney donor work-up and refer to the transplant centre for surgical assessment and for surgery). In the UK, there are 24 transplant centres and 50 non-transplant centres that are involved in live donor assessment. The questionnaire was addressed to the person responsible for the organization of live donor work-up either the live donor coordinator or the transplant programme director/lead. We requested the completed survey to be returned to us within 8 weeks. The study was closed in April 2011 and the centres that did not reply by the end of the study were considered as non-responders.
The questionnaire sent to 74 adult renal units in the UK. Adapted form of the questionnaire sent to all the renal centres in the UK; this is not the exact format of the survey but adopted to fit in the figure.
O R I G I N A L A R T I C L E
A s s e s s m e n t o f l i v i n g k i d n e y d o n o r s i n t h e U K R E S U LT S All of the centres performed living and deceased kidney donation. Live donor transplants varied from 11 to 143 (mean 69 ± 34) and the deceased donor transplants from 9 to 113 (mean 69 ± 23) per year across different centres. There were ∼102-670 patients (mean 298 ± 140) on the transplant waiting list at these centres during this period .
Of the 74 questionnaires sent, 21 of 24 (88%) transplanting and 23 of 50 (46%) non-transplanting units responded. The overall response rate was 60%. Taken together, the transplant centres which responded performed 917 (90% of the total) live and 1447 (86% of the total) deceased kidney transplants from April 2010 to March 2011. Of the 21 transplanting centres, 13 centres performed both ABO-incompatible and HLA-incompatible renal transplantations whereas 5 units performed only ABO incompatible transplants. Three transplant units carry out HLA and ABO compatible transplants only. The questionnaire was completed by the local renal department's transplant coordinator in 75% and by a consultant nephrologist, usually the transplant lead, in 25% of responding centres. The demographics of the 44 centres which responded to the questionnaire were obtained from the UK Renal Registery data, these include incident dialysis number, prevalent renal replacement therapy (RRT) rate pmp including transplant population. The number of patients in transplant centres on the transplant waiting list and the F I G U R E 2 : List of the 74 hub adult renal units in the UK including the 24 transplant centres in bold.
number of living donor transplants performed at the end of April 2011 were also included ( Table 1) .
Evaluation of the prospective live donor
Thirty-two per cent (14) of the centres receive a written consent from the potential donors prior to initiating the investigations and 45% (20) centres offer professional counselling.
Eighty-one per cent (17) of the transplanting units but only 30% (7) of the non-transplanting units have a dedicated live donor clinic. Eighty one per cent (17) of the transplanting centres and 26% (6) of the non-transplanting centres have a dedicated transplant live donor coordinator who is not involved in the recipient work-up. Fifty per cent (22) of the centres work up one potential donor at one time while 20% (9) work up two or more donors simultaneously. On average, most centres take about 3 to 6 months to complete donor assessment.
Age Eighty-six per cent (38) of the units are without an upper age limit for accepting donors and 7% (3) of the units accepted donors up to 75 years old. 70% (31) of units did not have a lower limit of donor age. Ten units exclude donors <20 years of age and three centres below the age of 21 ( Table 2) .
BTS guidelines recommend that individuals under the age of 18 should rarely if ever be considered as potential kidney donors unless sanctioned by the court.
Body mass index (BMI)
Forty-one per cent (18) of the centres accept donors with body mass indices (BMIs) up to 30, whereas 20% (9) and 20% (9) centres consider donors with BMIs up to 33 and 35, respectively. Interestingly 9% (4) of the centres did not have an upper limit for BMI ( Figure 3 ).
Proteinuria
Seventy per cent (31) of the centres rely exclusively on spot urine samples for protein quantification. Forty-three (19) of the units measure the albumin-creatinine ratio, whereas 64% (28) of units use the protein-creatinine ratio. Only 30% (13) of the responding centres perform 24-h urine collection (Table 3) .
Diabetes
All centres excluded individuals with fasting glucose >7.0 mmol from LKD. All centres reported that potential donors with fasting glucose between 5.9 and 6.9 mmol undergo an oral glucose tolerance test (OGTT) and are considered for donation only if the test is normal. Individuals at a high risk for type 2 diabetes like donors of South Asian or AfroCaribbean origin, first-degree family history of diabetes and obese donors routinely undergo OGTT in 9% (4), 60% (26) and 16% (7) of the responding centres, respectively (Table 3) .
Kidney function tests
All centres (100%) measure the isotopic glomerular filtration rate (GFR). The cut-off for the isotopic GFR acceptable for donation is according to the donor age. The minimal isotopic GFR for donors up to 40 years old is 86 mL/min/1.73 m 2 , while donors up to 80 years old must have an isotopic GFR of 50 mL/min/1.73 m 2 to be able to donate (Table 4) .
Seventy-five per cent (33) of the centres perform divided kidney function routinely, whereas 25% (11) centres perform this test only if there is a discrepancy in kidney size noted from other imaging studies.
Imaging of the prospective live donor Both computed tomography (CT) and magnetic resonance (MR) angiograms were used to study the renal vessels, and a conventional angiogram is not performed routinely. Sixtyone per cent (27) of the centres perform CT, whereas 32% (14) centres prefer MR angiogram.
Hypertension
All centres excluded donors with hypertension and evidence of end-organ damage. Thirty-two per cent (14) of the centres excluded all hypertensive donors on more than one antihypertensive drug. Sixty-four per cent (28) of units excluded donors only if they were taking more than two antihypertensive drugs. Four per cent (2) centres accepted patients on three antihypertensive drugs (Table 5 ).
Activation and suspension on the deceased waiting list in relation to LKD evaluation Recipients were suspended on the deceased transplant waiting list when donor assessment was complete in 18% (8) of the centres, after the final cross match in 11% (5) of the centres and once the theatre date was set in 36% (16) of the centres. One centre suspended the patient on the deceased waiting list only on the day of surgery.
Donor reimbursement of loss of earning was also inconsistent. Primary care and the hospital trusts reimburse donor expenses (expenses such as travel costs and loss of earnings) in 41% (18) and 25% (11) of centres, respectively; no response from others.
LKD in ABO-and HLA-incompatible donor-recipient pairs Twenty per cent (9) of the centres referred straightaway for ABO-or HLA-incompatible transplantation if that was the patient's choice. In contrast, 22% (10) centres listed incompatible donors in the paired pool for two runs, five centres for three runs and five centres for more than three runs before considering de-sensitization options for ABO-or HLA-incompatible transplant; each run in the parried pool is 3 months (Figure 4 ).
Donor follow-up
Post-donation, donors are followed by the hospital in 25% (11) centres and by joint care with their general practitioner in 48% (21) 
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D I S C U S S I O N
This study provides interesting insights into contemporary UK practice for LKD assessment. We are aware of four similar surveys of donor evaluation. In 1995, Bia et al. reported on a survey of 231 centres in the USA [11] . They described some degree of variation whereby larger centres tended to be less rigid in their exclusion criteria. More recently, Mandelbrot et al. carried out a similar survey in the USA and reported that, when compared with earlier data [11] , the medical criteria for donation were now more inclusive. The authors also noted considerable variability [12] . Gabolde et al. and others reported French data in 2001 [13] . They also noted considerable variability in LKD evaluation. Remarkably, the cut-off age for LKD, ranged from 45 to 75 years in that study [13] . Not surprisingly, Gabolde et al. suggested that practices should be codified into a set of guidelines [13] . In this regard, it is worthwhile remembering that the studies by Bia et al. [11] and Mandelbrot and others [12] also surveyed current practice in the absence of nationally established and agreed LKD guidelines. Uniquely, such guidelines have been in place in the UK for a number of years. Their current, revised, form dates from 2011 [10] . Lumsdaine surveyed current practice in LKD evaluation in 1999 [14] but their data predates the advent of the first UK LKD guidelines. These authors also noted considerable variation regarding organization of LKD work-up, as well as investigations and acceptance criteria and also called for LKD guidelines [14] .
Our study surveyed, for the first time, current practice of LKD assessment in 44 UK renal units, both in transplanting and non-transplanting centres. The responding centres were responsible for the majority of LKD workload in the UK in 2010, which gave us further confidence in assuming that our study is representative of current UK practice.
First, the infrastructure for LKD evaluation was variable between centres, with significant differences in practice in the staff leading the live donor programme, the existence of dedicated live donor clinics and the presence of a dedicated transplant coordinator to organize live donation. Of note, only 30% of the non transplanting units involved in LKD work-up have a dedicated live donor clinic. This finding begs the question as to how these centres maintain a consistent and streamlined approach in their potential donors. National and regional policy makers and commissioners need to consider what the minimum workload of a successful LKD work-up programme should be and define minimum standards for the infrastructure of LKD work-up. This should, we believe, include a dedicated live donor clinic. 
O R I G I N A L A R T I C L E
Second, our survey demonstrated that 86% of UK units are without a set upper age limit for donors, whereas 7% of units excluded all potential donors older than 70 years. The lower limit of age that units accept is also variable: In the UK, 16 years is the legal age for provision of informed consent; however, in the present study, 10 units exclude donors <20 years of age. Studies from other countries have previously detected considerable variability regarding the donor age, most notably that of Gabolde et al., who reported that some French units excluded donors beyond the age of 45 [13] . Our results are particularly noteworthy, given that current UK guidelines explicitly state that old age alone is not an absolute contraindication to donation [10] . We find it difficult to understand why some renal units decide to ignore current guidelines and exclude potential donors on the basis of age alone. The issue has recently attracted public interest in the UK after an 83-year-old man became the UK's oldest altruistic kidney donor [15] .
British Transplantation Society guidelines suggest that healthy overweight (BMI: 25-30) donors may safely donate and moderately obese (BMI 30-35) donors could be considered only after a careful evaluation, and 20% of the units accept BMI up to 33. This study showed a remarkable variation in regard to BMI. Forty-one per cent of the units accept donors with BMIs of up to 30, 20% of centres consider donors with a BMI of up to 33 and another 20% up to BMI 35. The issue is of great importance, since the BMI is on the increase globally [16] , concurrent with an increase in obesityassociated morbidity and mortality [17] . Long-term outcomes in moderately obese (BMI 30-35) donors are not well described, although the negative impact of obesity on renal outcomes in the general population has been extensively studied [18, 19] . In addition, obesity has been shown to worsen outcomes after unilateral native nephrectomy. Obese patients, defined as having a BMI >30, almost universally developed proteinuria after nephrectomy, and had a much higher rate of chronic kidney disease compared with those with a BMI <30 [20] . These findings suggest that the increased attention to obesity in donors is appropriate, and that caution is warranted in evaluating donors with a BMI of over 30, especially if the BMI is over 35. It is all the more surprising that 9% of the centres still did not have a cut-off for BMI. Discussions with potential donors around BMI are increasingly common in our own daily practice and variability in BMI criteria may tempt motivated donors to 'shop around' for a programme that will accept them.
Furthermore, our study showed inconsistencies in assessing proteinuria with most programmes relying on a spot 
Centres considering number of runs in paired pool prior to referral for ABO-or HLA-incompatible transplantation.
urine sample for protein quantification, whereas 30% of the centres still perform 24-h urine collection. Forty-three per cent of the units measure the albumin-creatinine ratio, whereas 64% units use the protein-creatinine ratio. In this regard, the UK guidelines are somewhat vague in that all of these tests are regarded as acceptable means of testing for proteinuria.
The variability regarding hypertensive donors in our study is also remarkable. Sixty-four per cent of the units excluded donors only if they were taking more than two antihypertensive drugs, whereas 32% of the centres excluded all hypertensive donors on more than one antihypertensive drug. Notably, 4% of the centres accepted donors on three antihypertensive drugs as well. In this regard, the current UK guidelines stipulate that the presence of mild-moderate hypertension that is controlled with one to two antihypertensive agents is not a contraindication to kidney donation provided significant end-organ damage has been excluded [10] .
Our study showed less variability in regard to diabetes, although there was variability in potential donors at risk of the disease. All centres reported that potential donors with fasting glucose between 5.9 and 6.9 mmol undergo an OGTT and are considered for donation only if the test is normal, which is in accordance with the UK LKD guidelines. However, individuals at a high risk for type 2 diabetes (gestational diabetes, 1st degree family history of diabetes, obesity, South Asian or Afro-Caribbean origin) routinely underwent OGTT in only 40% of responding centres. This is in stark contrast to the LKD guidelines, which recommend that prospective donors with an increased risk of type 2 diabetes because of family history, ethnicity or obesity should also undergo an OGTT [10] . This widespread practice is all the more disturbing in view of increasing concerns that donors may develop obesity and type 2 diabetes after donation, in parallel to trends in the general population in industrialized countries [21] . Discussions about increased BMI and risk of diabetes are becoming more and more common in our own clinical practice. Again, we believe that a consistent approach would be desirable.
We also demonstrate variability regarding the imaging used to evaluate potential live donors. Sixty-one per cent of centres perform CT angiography to assess renal vessels prior to donation, while 32% use MR angiography. Current UK guidelines do not stipulate the imaging modality of choice, reflecting a lack of robust evidence. Studies suggest that CT and MR angiography each have advantages and disadvantages but remain equivocal as to which of the two may be superior for LKD evaluation [22, 23] . One could ask whether this issue really matters, were it not for the difference in cost associated with these two procedures. In most health systems, MR angiography will be considerably more expensive than its CT equivalent. The lack of clear guidance in the current UK guidelines may therefore put clinicians in a difficult position when they negotiate imaging with radiologists and managers. The same issue applies to radionuclide scanning, which again is a costly test. In our study, 75% of centres assess split kidney function by radionuclide testing in all potential donors whereas 25% use this test only if there is a discrepancy in kidney size. As far as we are aware there is no strong evidence on the importance of split kidney function in the absence of a difference in kidney size. Accordingly, the current UK guidelines recommend such imaging only in the presence of a difference in kidney size [10] .
In addition, our data depict substantial differences in work-up strategy. Fifty per cent of the centres work-up one potential donor at one time, while 20% work up two donors simultaneously, which has implications on NHS resources and cost if two or more donors are worked up in the same time, while only one might be a donor. There is also inconsistency in regard to suspension of the recipient with potential live donor from the deceased waiting list, whereby 18% of centres removed recipients from the deceased transplant waiting list when donor assessment was complete whereas 36% of centres did this only once the theatre date was set in. As far as we are aware, there are currently no data indicating the optimal strategy in this regard. A difficult situation may arise when a recipient with a fully worked up live donor has been called in after a deceased donor has become available. We believe that a recipient should be suspended on the deceased transplant list when a potential live donor has been identified, living kidney donation is the better option compared with a kidney from a deceased donor [1] , especially if the recipient is young and likely to need more than one kidney in life, to avoid desensitisation and make the second kidney transplant easier to match with. We also feel that the guidelines should address this point to avoid inconsistency. Along similar lines, our study shows an inconsistent approach towards blood group and HLA-incompatible donorrecipient pairs and the decision as to when such pairs should be included in the paired-pooled programme, and when to proceed to ABO-or HLA-incompatible LKD. Again, we believe the latter are limited and costly resources and a consistent approach would be beneficial and avoid difficult discussions with patients and potential donors.
Our study has limitations as well. Our data represent practices as they are reported, and we cannot confirm how accurately they reflect actual practice. We cannot ascertain whether the reported data are fully representative of local practice or whether indeed some clinicians adopt different practices within the same centre. In addition, we cannot exclude the possibility of a systematic bias among programmes that chose to respond compared with programmes that did not. Finally, this survey was sent in 2011 during the time of drafting the new version of the UK living donation guidelines and it will be interesting to know how those guidelines will change practices towards living donor evaluation in future.
We report remarkable variation in many aspects of LKD evaluation in the UK. These pertain to the logistics of LKD work-up, but also to investigations and tests employed for LKD evaluation. We also note that the time to complete live donor assessment in most centres is up to 6 months. Current UK practice is also remarkably inconsistent when it comes to suspension on the deceased renal transplant waiting list in relation to the stage of LKD evaluation. Variability also includes acceptance criteria, with substantial differences regarding age, hypertension and BMI. This is of particular concern as increasing numbers of potential living donors now have medical conditions that may be associated with future health risk, most notably increased BMI and hypertension [21] . We speculate that the lack of evidence regarding a correlation between these variables and LKD outcomes is the underlying cause for this variability. Further data from LKD registries should facilitate more robust guidelines.
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